Alpha Partners
Alpha Partners is a venture capital firm based in New York, specializing in co-investments in established companies across various stages, including early, growth, and later stages. Founded in 2014, the firm primarily focuses on sectors such as software, information technology, e-commerce, and tech-enabled services. Alpha Partners aims to support early-stage venture capital firms by providing on-demand capital for follow-on investments in their leading companies, thus addressing capital constraints faced by these funds. The firm typically invests between $0.15 million and $2 million in companies with revenues ranging from $5 million to $20 million, with a goal to exit investments within four years. Alpha Partners does not take board seats in portfolio companies and prefers to act as a co-investor rather than a lead investor.
Intellibox is a patented technology which makes it quick and easy for customers to sell their phone for cash. Customers can take their used mobile phones to an Intellibox, complete the evaluation in 5 mins and walk away with 100s of pounds.
LiveIntent is a marketing technology platform that specializes in enhancing email as a powerful tool for identity resolution and targeted marketing. Serving over 2,000 brands and publishers worldwide, LiveIntent transforms traditional email communication into a robust mechanism for customer engagement and revenue generation in a mobile-first environment. The platform creates a private customer graph that supports various marketing objectives, including acquisition and attribution. Headquartered in New York City, LiveIntent has additional offices in cities such as Berlin, Chicago, and Los Angeles, employing around 170 people. Its full-service email advertising solutions cater to the needs of both marketers and publishers, positioning the company as a leader in the email marketing landscape.
Metra Biosystems
Venture Round in 1992
Metra Biosystems develops and commercializes diagnostic products for the detection and management of metabolic bone and joint diseases and disorders.
Metra Biosystems
Venture Round in 1992
Metra Biosystems develops and commercializes diagnostic products for the detection and management of metabolic bone and joint diseases and disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.